Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. - Wikidata - awgldk - TriplyDB

Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome.

Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome.

http://www.wikidata.org/entity/Q39721007

about

Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN)Neurocognitive and Neuroplastic Mechanisms of Novel Clinical Signs in CRPS Short-Term Functional, Emotional, and Pain Outcomes of Patients with Complex Regional Pain Syndrome Treated in a Comprehensive Interdisciplinary Pain Management Program.Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®NK cells mediate the cumulative analgesic effect of electroacupuncture in a rat model of neuropathic pain.Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome A Comprehensive Outcome-Specific Review of the Use of Spinal Cord Stimulation for Complex Regional Pain Syndrome.Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment Anti-cytokine autoantibodies in postherpetic neuralgia.New Concepts in Complex Regional Pain Syndrome.Chronic pain as a manifestation of potassium channel-complex autoimmunity Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies.Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome.Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema.A review of epidural catheter-related infections.Imaging and clinical evidence of sensorimotor problems in CRPS: utilizing novel treatment approaches.Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.Mechanism-based treatment in complex regional pain syndromes.Prophylactic treatment with sulphonated immunoglobulin G attenuates development of mechanical allodynia-like response in mice with neuropathic pain.Pain in autoimmune disorders.Management of adult patients with long-standing complex regional pain syndrome.Long-term outcomes of totally implantable venous access devices.Immunoglobulin maintenance therapy in long-standing complex regional pain syndrome, an open study.Improving the diagnosis and treatment of CRPS: insights from a clinical immunologist's personal experience with an underrecognized neuroinflammatory disorder.[Current aspects of the therapy of complex regional pain syndrome].Identification of KRT16 as a target of an autoantibody response in complex regional pain syndrome.Passive transfer autoimmunity in a mouse model of complex regional pain syndrome.Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases.Critical updates in the 7th edition of the American Society for Apheresis guidelines.Autoantibodies in Chronic Obstructive Pulmonary Disease.Complex regional pain syndrome-up-to-date.Complex Regional Pain Syndrome (CRPS): High risk of CRPS after trauma in another limb in patients who already have CRPS in one hand or foot: Lasting changes in neural pain modulating systems?The Rodent Tibia Fracture Model: A Critical Review and Comparison with the Complex Regional Pain Syndrome Literature.Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome.Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange.7th International Immunoglobulin Conference: Interlaken Leadership Awards.Bitte nicht noch mehr verletzen!

P2860

Q24622752-666EC100-694E-4E58-B925-DF01F138134F Q26767520-A2389C52-D441-4A8D-8F1A-D5CFC55B78A0 Q30376747-EE31F704-AC76-4FD8-AB38-1A543C55AE53 Q33167702-4C8A36F6-2172-4577-AD09-0E7CCFD47FE1 Q34123628-D20273FB-C079-4E12-A1A5-AB7484D517AD Q34161527-DDD2935C-FD76-4C11-823F-3C05EE34358A Q34542606-575F4BD1-A365-4031-A7E9-C14EF3BED494 Q34614091-D34E45A4-AB64-4132-BAFC-0202F49852CD Q35680023-71FC9A34-E624-48FF-AB62-F8C73B621198 Q36198740-4E2E9E6D-A8BC-4263-B3AF-CB5EDB9ACC00 Q36327294-355AF30F-5331-49BF-8762-19D9477650A1 Q36475267-9D2D015A-2A49-46EC-8ECD-5FC203570A1B Q36484460-EB2F584B-9C92-4159-A693-577D56DB3A6F Q36868585-BA100DF2-5D91-4711-81B4-34BA78D02E66 Q37020591-889EBEE7-1390-4880-9B4D-742A1341FF40 Q37682101-62729E82-52AE-442F-A9CF-22F81932BE7E Q38012083-212347EF-7B94-4D1C-BB6F-F491818C16F5 Q38051126-2BBF9182-FA5E-48CE-B7AB-618CFB9AE483 Q38207936-D020735E-D2F0-4481-AB5A-574DCACF1BB0 Q38240995-97E899B9-2F7F-4B2E-853E-47ADA33473F6 Q38372972-7A3EED70-C002-4548-9786-21EDC460589C Q38905689-3AA0558A-764F-43B9-B64A-1AF295B7391F Q39209908-887D2B8A-124F-4403-A2C0-8D54A7EBBA1A Q40339217-90F08D54-9DAB-432E-BE06-3B4BCA1308B9 Q42617642-DE08E410-6FC9-4E44-B992-72F57EC03579 Q44775234-A89082B7-FE34-48FC-9EEE-5904019AF61B Q46198933-7969119B-6835-4E51-A31D-1243AA2B6DEA Q47138335-0FDB83FF-D5EC-47FC-AE0F-D50E06FBCCC8 Q47254079-E8737A2C-F28D-457A-A180-79E09624E097 Q47434847-E382EB2F-636F-4D44-925A-B918906849A9 Q47880572-9DCA8E2A-5C0F-40F4-9AD8-2E28287C51CF Q48217985-0EBAFF1B-D886-4D77-9E3B-76FC8D3DF79C Q49222442-168862C4-2B4F-4467-898D-F5CDAA1A7B4B Q49296314-CF089FD1-7FA0-46F3-AA28-CCF6A9015B82 Q50283809-B83CC125-57BB-42FB-BE64-A991EE54BE57 Q52312548-3A6F49BB-9AFB-43D4-A86F-E0AB503D8299 Q52324612-93F2EBA7-0AD3-4471-BE1E-633413C8BE51 Q52866222-EF2CA195-0EEF-4E1A-BF5C-45F883F3CAE7 Q54299706-FA39101B-BBDB-471B-AE6B-6BEE3E86C298 Q57522356-9575C298-37E0-402D-8600-10B4295F9BF5

P2860

Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome.

http://www.wikidata.org/entity/Q39721007

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Autoimmunity against the β2 ad ...... omplex regional pain syndrome.

@en

Autoimmunity against the β2 ad ...... omplex regional pain syndrome.

@nl

type

label

Autoimmunity against the β2 ad ...... omplex regional pain syndrome.

@en

Autoimmunity against the β2 ad ...... omplex regional pain syndrome.

@nl

prefLabel

Autoimmunity against the β2 ad ...... omplex regional pain syndrome.

@en

Autoimmunity against the β2 ad ...... omplex regional pain syndrome.

@nl

P1433

Q39721007-CDCF1EAD-1A81-4E39-986D-6F25EAF186AB

P1476

Q39721007-03F36D46-1E64-49A6-9750-837DA62BC775

P2093

Q39721007-09A0BE29-490A-4ECF-A175-6C52C809FE15

Q39721007-0AC1F5B4-DA50-41D6-832B-486E5DB41CDF

Q39721007-10F89B9D-A61B-47C2-9212-9B847897EA06

Q39721007-17F78ABD-7570-4099-8D35-F1E0B6F9BD7D

Q39721007-38B0D652-075F-4F6F-AD71-1BE7D66CE5DF

Q39721007-49CAD5FA-62EA-4035-91B4-C9C40A9C3C06

Q39721007-9105E0AC-5CFF-46B8-B078-B576D7C7A883

Q39721007-BED35FB9-4B39-477F-A96F-7206695D4744

Q39721007-BFB81F65-2E17-494A-9CAC-63B55AE52529

Q39721007-FF2AE92E-BFCC-46ED-A449-14FF6F147560

P304

Q39721007-615A3359-2522-438A-9E1A-3E4D8A633A36

P31

Q39721007-AF817414-8D91-4288-A25D-7DCC3A72467B

P356

Q39721007-F8EA13EA-8FA9-4380-8703-28E437D1C762

P407

Q39721007-0557231A-FE64-4AAF-9C1E-27B515738210

P433

Q39721007-2EF52E0A-49CC-45A8-BE51-C4DEE00C0B5C

P478

Q39721007-FFAF529D-F457-4C62-8322-4500D8327D65

P50

Q39721007-3867711A-C7C5-4F6F-9168-A8F416AA7271

Q39721007-F8599647-4E77-49CB-83EF-641A088D4FD1

P577

Q39721007-AD6D8CF4-473A-4D13-B206-0DAD816C152E

P698

Q39721007-20BD4849-1F86-4726-B81C-085DBD90C3B9

P356

J.PAIN.2011.06.012

P1433

P1476

Autoimmunity against the β2 ad ...... omplex regional pain syndrome.

@en

P2093

Andreas Goebel

http://www.w3.org/2001/XMLSchema#string

Danielle Kohr

http://www.w3.org/2001/XMLSchema#string

Ervice Pouokam

http://www.w3.org/2001/XMLSchema#string

Frank Birklein

http://www.w3.org/2001/XMLSchema#string

Franz Blaes

http://www.w3.org/2001/XMLSchema#string

Manfred Kaps

http://www.w3.org/2001/XMLSchema#string

Marlene Tschernatsch

http://www.w3.org/2001/XMLSchema#string

Martin Diener

http://www.w3.org/2001/XMLSchema#string

Pratibha Singh

http://www.w3.org/2001/XMLSchema#string

Wolfgang Kummer

http://www.w3.org/2001/XMLSchema#string

P304

2690-2700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PAIN.2011.06.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

152

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21816540

http://www.w3.org/2001/XMLSchema#string